Alembic Limited

Nurturing global well being since 1907

Presented By:
Avni Jain (20)
 Mission:

We always intend to give access to the best healthcare

products at affordable price to everyone, anywhere in the
world
About
 Alembic started in 1907
 Asia's most respected integrated pharmaceutical company
 Regd. Office: Alembic Road, Vadodara
 Manufacturing facilities in Baroda and Baddi, India
 Operations:
 Domestic Formulation Sales
 Export Formulations
 Domestic API sales
 Export API
 Contract/ collaborated Research Services

 Promoters:
 No. of shares held: 8,47,53,005
 % of voting strength: 61.78

 The Board has recommended dividend on Equity Shares at Rs.0.40 per share i.e.20% for the year ended on
31.03.2009


Certification
 Alembic is a certified
 ISO-9002 ,
 ISO-14001 and
 ISO 27001

 Conforms to WHO-GMP guidelines ensuing that

every Alembic product meets the most stringent
quality standards.
Albemic group of companies
 Shreno Limited [Glass Division]  

 Shreno Limited [Engg. Division]

 Paushak Limited
Restructuring and its key benefits
 Alembic went a
restructuring in this
fiscal year
 to streamline
products into tighter
well- focused
segments
 sharpen the
effectiveness of the
sales force
Growth Ignitions
 Alembic released 34
new products in
2008-09 compared
to 25 in 2007-08

 Contributed 3.54% to
the domestic
branded formulations
sales
Brand Domination
 Azithral
 consolidated its No. 1 position in its category
 recorded a 30% growth.
 It also catapulted 12 places from its last year rank
of 39 to become the 27th top selling brand in the
country.*

* Source: ORG (MAT),March '09.

Top ten brands

* Source: ORG (MAT),March '09.

R&D
 The total investment in R&D this year was Rs. 47.7 Crores, which
was 4.21% of consolidated net sales.

 Alembic Research Centre is 1,45,000 sq. Ft. build on state of art

 It houses 250+ scientists
IPR
 “IPR Knowledge Contribution to Society
Enhancement” initiative was launched to focus on
enhancing IPR competency across the
organization.

 This year Alembic accelerated its patent filing

process by filing 54 patent applications
International Footprint
Financial Highlights 2008-09
• 10.4% increase in total revenue

• 44% growth in International Business

• 71% growth in sales to regulated markets

• 54% growth in API sales

• 34 new domestic formulations product launched

• 6 of the domestic brands featured amongst ORG top 300 brands

• 14th most prescribed Company by Indian doctors

Share Price and Sensex
Listing of Shares
 Bombay Stock Exchange Limited (BSE)

 National Stock Exchange of India Limited

(NSE)
Work Culture at Albemic
• Share collaborative & symbiotic relationships with
our employees.

• The environment at Alembic can be defined as

positive, built on mutual strengths.

• They value openness and teamwork in our

interpersonal dealings.

  
Thank You